Clinical Trial Update: Pharmacokinetics and Dynamics of Nebulized Dexmedetomidine [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates on pharmacokinetics and dynamics of nebulized dexmedetomidine reported by Assiut University; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Cancer

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Assiut University | Conditions: Abdominal Cancer | Phase 1, Phase 2 | Status: UNKNOWN